Personalised mRNA melanoma vaccine cuts risk of tumour recurrence in late-stage trial results
Results from a personalised mRNA melanoma vaccine trial are being called a major step forward for the platform, with experts weighing whether it can transform t
The Institute of Cancer Research (ICR) · +14 outlets
FDA grants accelerated approval to Inovio's DNA immunotherapy Voceryq for recurrent respiratory papillomatosis
The approval is the first DNA immunotherapy cleared in the US, and Precigen shares fell 27% after hours on the news.
HCPLive · +7 outlets
FDA approves GSK's functional cure for hepatitis B
The clearance gives hepatitis B patients a therapy designed to achieve a functional cure rather than chronic suppression.
Drug Discovery News · +14 outlets
Hyderabad startup PopVax uses AI for personalised mRNA cancer vaccines, targets 100+ doses in 12 months
The India-based company says it aims to manufacture more than 100 personalised mRNA cancer vaccines within a year.
Startup Pedia · +1 outlets
First patient receives pioneering stem-cell treatment for Parkinson's disease
The procedure marks an early clinical test of stem-cell therapy as a treatment approach for Parkinson's.
Medical Xpress · +8 outlets
UK clears Casgevy gene therapy for children as young as five, NHS funding unresolved
The expanded clearance widens eligible ages for the CRISPR-based sickle cell therapy, but reimbursement questions remain.
Tech Times · +2 outlets
Genmab bispecific cancer drug cuts death risk by 50% in head and neck cancer
The data adds to a growing field of bispecific antibodies being tested in solid tumours.
Drug Discovery News · +13 outlets
Merck sharpens personalised cancer strategy as stock rises
Merck is positioning its oncology franchise around more targeted approaches amid intensifying competition in cancer drugs.
TheStreet
Iovance stock crashes on surprise lung cancer trial twist
The cell therapy developer's shares fell sharply after unexpected results from a lung cancer study.
Investor's Business Daily · +5 outlets
FDA proposes withdrawing Tavneos approval in the US
The proposal would remove the vasculitis drug from the US market, a rare move against an approved therapy.
UA.NEWS · +10 outlets
Family funding helps bring Sanfilippo gene therapy to patients
Family-led fundraising provided a critical boost to gene therapy research for the rare lysosomal disorder Sanfilippo syndrome.
SuaraGarut.ID · +5 outlets
FDA approves first DNA immunotherapy for RRP
The approval covers a DNA-based immunotherapy for recurrent respiratory papillomatosis, with Precigen shares reacting sharply.
Voice of Healthcare · +8 outlets
Pretzel Therapeutics wins UK approval to advance PX578 into Phase II for rare mitochondrial disease
The clearance moves the mitochondrial disease candidate into mid-stage testing in the UK.
BioPharma APAC
FDA announces new initiative for rare diseases
The agency is rolling out a new program aimed at accelerating development of rare disease treatments.
Drug Discovery News · +14 outlets
Blood mRNA model predicts castration resistance in metastatic prostate cancer
A blood-based mRNA signature could help identify prostate cancer patients likely to stop responding to hormone therapy.
CancerNetwork
K-biotech trails China and India in biosimilar race, prepares Keytruda counterattack
South Korea's biotech sector has zero biosimilar approvals versus 17 for China and India, and is plotting a response around Keytruda.
BigGo Finance
Sellas SLS009 AML trial spotlights drug combo with AbbVie, Roche and Bristol Myers drugs
The trial pairs Sellas' candidate with marketed therapies in an effort to improve acute myeloid leukemia outcomes.
Stocktwits
Newly discovered pathway fuels production of cancer-driving proteins
The finding points to a potential new target for drugs aimed at proteins that drive tumour growth.
Medical Xpress